Turning cancer into a curable disease: Immunotherapy expert John Connolly picks up the reins as the new CSO of Sean Parker’s cancer institute

John Connolly synced with the folks at the Parker Institute for Cancer Immunotherapy early on. As the science chief at Singapore-based Tessa Therapeutics, he worked on a next-gen CAR-T with an amped up package of T cells. But the same immunotherapy focus runs right through his days teaching at Baylor